Detalhe da pesquisa
1.
A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer.
Support Care Cancer
; 26(6): 1905-1915, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29275525
2.
Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer.
Cancer Chemother Pharmacol
; 88(6): 1033-1048, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618197
3.
PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta®): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers.
Adv Ther
; 37(7): 3370-3391, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524499
4.
Genetically modified mesodermal-derived cells for bone tissue engineering.
IEEE Eng Med Biol Mag
; 22(5): 57-64, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14699937